Use of a functional classification of anemia in myelodysplastic syndromes to identify subgroups of patients responsive to recombinant human-erythropoietin therapy.
Bucalossi
A
A
Marotta
G
G
Bigazzi
C
C
Galieni
P
P
Vessihelli
F
F
Falbo
R
R
Dispensa
E
E
D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000145:classification* / Q000188:drug therapy* / Q000235:genetics; D015415:Biomarkers; D004921:Erythropoietin / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007621:Karyotyping; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000145:classification* / Q000188:drug therapy* / Q000235:genetics; D011990:Receptors, Transferrin / Q000032:analysis; D011994:Recombinant Proteins / Q000627:therapeutic use
D015415:Biomarkers; D011990:Receptors, Transferrin; D011994:Recombinant Proteins; D004921:Erythropoietin